According to the Tianyancha App, on September 14, Xichuang Yuang Innovative Drug Research and Development Co., Ltd. was established. The legal representative is Zhu Guorong, with a registered capital of 1 million yuan. The business scope includes medical research and experimental development, sales of first-class medical devices, sales of experimental analytical instruments, intellectual property services, import and export of goods, technology import and export, etc. According to shareholder information, Zhejiang Tianyu Pharmaceutical Co., Ltd., West Lake Innovative Enterprise Management Co., Ltd., and Zhejiang Tongkaibest Biotechnology Co., Ltd. hold 55%, 40%, and 5% of the shares respectively. Among them, Tianyu Co., Ltd. is the largest shareholder and has pledged an investment of 550,000 yuan.

According to the Tianyancha App, on September 14, Xichuang Yuang Innovative Drug Research and Development Co., Ltd. was established. The legal representative is Zhu Guorong, with a registered capital of 1 million yuan. The business scope includes medical research and experimental development, sales of first-class medical devices, sales of experimental analytical instruments, intellectual property services, import and export of goods, technology import and export, etc. According to shareholder information, Zhejiang Tianyu Pharmaceutical Co., Ltd., West Lake Innovative Enterprise Management Co., Ltd., and Zhejiang Tongkaibest Biotechnology Co., Ltd. hold 55%, 40%, and 5% of the shares respectively. Among them, Tianyu Co., Ltd. is the largest shareholder and has pledged an investment of 550,000 yuan.